Creating Value Through Intelligent Borrowing

Creating Value Through Intelligent Borrowing

Tim Opler Tim Opler

Tim Opler

Managing Director at Stifel

发布日期: 2019年11月15日
+ 关注

The Evolving Landscape of the Life Sciences Debt Market

Download Full Presentation

Torreya’s report provides an overview of the evolving landscape of the Life Sciences debt market.

Key points include:

  • Debt is lightly used by life sciences companies.
  • The direct private debt market for life science companies has grown dramatically.
  • As the value of debt becomes more recognized, the landscape of borrowers is evolving.


David Clive Price Ph.D.

Wellbeing and Life Coach | Author of Hidden Demons Book & Method | Helping You Overcome Stress, Anxiety and Depression to Rebalance Your Life, Refind Your Purpose and Create Abundance

5 年

Quite an insightful read!

赞
回复
Pamela Demain

Senior Vice President, Business Development at NImmune Biopharma

5 年

Always great things coming from Torreya Partners. Thanks Tim!

赞
回复
1 次回应
查看更多评论

要查看或添加评论，请登录

Tim Opler的更多文章

  • Do Reverse Mergers Create Value?
    2022年6月1日

    Do Reverse Mergers Create Value?

    Download Study As of this writing we find ourselves in an extraordinary moment in biotech history. More than 190…

    9 条评论
  • The Pharma 1000
    2021年11月8日

    The Pharma 1000

    In today's publication of the Pharma 1000, we rank the world's top 1000 biopharmaceutical companies by value. Download…

    23 条评论
  • Biopharma Sector Update
    2021年10月5日

    Biopharma Sector Update

    Download the Report In this report, we examine the financing and deal environment for the biopharma sector, with…

    3 条评论
  • Biopharma Sector: What's to Come in '21?
    2021年1月11日

    Biopharma Sector: What's to Come in '21?

    A Torreya Report on Top Biopharmaceutical Industry Developments of 2020 and Outlook for 2021 DOWNLOAD THE REPORT (pdf)…

    9 条评论
  • Biopharma Deal and Market Update
    2020年10月29日

    Biopharma Deal and Market Update

    October 29, 2029 Download the Presentation: Key points in the Presentation We remain in a COVID-19 pandemic. With…

    1 条评论
  • Astellas to Acquire iota Biosciences
    2020年10月15日

    Astellas to Acquire iota Biosciences

    Accelerate Rx +? business by acquiring innovative technology for ultra-small implantable medical devices and…

    14 条评论
  • Flame Biosciences Announces $100 Million Common Stock Financing
    2020年9月30日

    Flame Biosciences Announces $100 Million Common Stock Financing

    Flame Biosciences Announces $100 Million Common Stock Financing to Further Advance Drugs Targeting Inflammasome for…

    14 条评论
  • The World’s Most Valuable Pharmaceutical Companies
    2020年9月23日

    The World’s Most Valuable Pharmaceutical Companies

    Download the Report Torreya’s “Pharma 1000” report provides a snapshot of the global pharmaceutical industry in…

    15 条评论
  • Biopharma Financing Environment at Record Level
    2020年5月29日

    Biopharma Financing Environment at Record Level

    Nasdaq Biotech Index hits an all-time record this month consistent with massive reallocation into innovative life…

    3 条评论
  • Outlook for Biopharma Financing and Deals During the COVID-19 Pandemic
    2020年4月21日

    Outlook for Biopharma Financing and Deals During the COVID-19 Pandemic

    Download the Torreya Report April 21, 2020 This Torreya report shows how the COVID-19 pandemic has impacted the…

    10 条评论

社区洞察

其他会员也浏览了